COMMUNIQUÉS West-GlobeNewswire

-
CooperCompanies Announces Release Date for Third Quarter 2025
24/07/2025 -
Rakovina Therapeutics Announces Warrant Exercise Incentive Program
24/07/2025 -
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
24/07/2025 -
Algernon Announces Closing of the Private Placement Financing
24/07/2025 -
Scienture Holdings, Inc. Obtains $1.2 Million in Bridge Funding
24/07/2025 -
Natural Brain Support Without the Crash: Lives Potions Introduces Plant-Based Cognitive Enhancement
24/07/2025 -
Guerbet : Chiffre d’affaires du 1er semestre 2025
24/07/2025 -
Guerbet : H1 2025 revenue
24/07/2025 -
Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics
24/07/2025 -
Fairhaven Health Strengthens Women’s Health Commitment Beyond Fertility
24/07/2025 -
Approbation de Cabometyx® dans l’UE pour les tumeurs neuroendocrines avancées précédemment traitées
24/07/2025 -
Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors
24/07/2025 -
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit
24/07/2025 -
Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call
24/07/2025 -
Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025
24/07/2025 -
Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025
24/07/2025 -
Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer
24/07/2025 -
Natural Appetite Suppressant: Why PhenQ Is the Safer Choice Over Weight Loss Injections in 2025
24/07/2025 -
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market
24/07/2025
Pages